Diplopia differential diagnosis: Difference between revisions
No edit summary |
|||
Line 119: | Line 119: | ||
|Mitochondrial myopathies<ref name="pmid21730846">{{cite journal |vauthors=Schrier SA, Falk MJ |title=Mitochondrial disorders and the eye |journal=Curr Opin Ophthalmol |volume=22 |issue=5 |pages=325–31 |date=September 2011 |pmid=21730846 |doi=10.1097/ICU.0b013e328349419d |url=}}</ref> | |Mitochondrial myopathies<ref name="pmid21730846">{{cite journal |vauthors=Schrier SA, Falk MJ |title=Mitochondrial disorders and the eye |journal=Curr Opin Ophthalmol |volume=22 |issue=5 |pages=325–31 |date=September 2011 |pmid=21730846 |doi=10.1097/ICU.0b013e328349419d |url=}}</ref> | ||
| | | | ||
* Dominant | * Dominant optic atrophy (OPA1 gene mutation) | ||
* Leber | * Leber hereditary optic neuropathy (point mutation in mitochondrial DNA) | ||
* Chronic | * Chronic progressive external ophthalmoplegia also known as Kearns-Sayre syndrome (TYMP, ANT1, PEO1, POLG, POLG2, and even OPA1 gene mutations) | ||
| | | | ||
* Retinal ganglion cells and nerve fiber layer of the retina affected in dominant optic atrophy (may lead to blindness) | * Retinal ganglion cells and nerve fiber layer of the retina affected in dominant optic atrophy (may lead to blindness) | ||
Line 129: | Line 129: | ||
** | ** | ||
| | | | ||
* Chronic | * Chronic progressive external ophthalmoplegia: | ||
** Restriction of eye movements | ** Restriction of eye movements | ||
** Visual acuity is spared | ** Visual acuity is spared | ||
** Ptosis | ** Ptosis | ||
* Leber | * Leber hereditary optic neuropathy: | ||
** Disc pseudoedema | ** Disc pseudoedema | ||
** Thickening of the retinal nerve fiber layers | ** Thickening of the retinal nerve fiber layers | ||
Line 145: | Line 145: | ||
** Sectoral pallor of the optic nerve | ** Sectoral pallor of the optic nerve | ||
|- | |- | ||
|Muscular dystrophy | |Muscular dystrophy<ref name="urlOculopharyngeal Muscular Dystrophy - NORD (National Organization for Rare Disorders)">{{cite web |url=https://rarediseases.org/rare-diseases/oculopharyngeal-muscular-dystrophy/ |title=Oculopharyngeal Muscular Dystrophy - NORD (National Organization for Rare Disorders) |format= |work= |accessdate=}}</ref> | ||
| | | | ||
* Oculopharyngeal muscular dystrophy (Mutations of the polyadenylate binding protein nuclear 1, PABPN1 gene) | |||
* Oculopharyngodistal myopathy | |||
| | | | ||
* Dysphagia | |||
* Weakness of proximal muscles (distal muscles in case of oculopharyngodistal myopathy) | |||
* Atrophy of the tongue | |||
* Weakness of facial muscles | |||
* Dysphonia | |||
| | | | ||
* Ptosis | |||
|- | |- | ||
| colspan="1" rowspan="2" |Neuromuscular junction dysfunction | | colspan="1" rowspan="2" |Neuromuscular junction dysfunction |
Revision as of 15:36, 18 February 2019
Diplopia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diplopia differential diagnosis On the Web |
American Roentgen Ray Society Images of Diplopia differential diagnosis |
Risk calculators and risk factors for Diplopia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Diplopia may be caused by disorders of the orbit, extraocular muscles, neuromuscular junction dysfuntion, paralysis of the oculomotor, trochlear and abducens nerves, and injuries affecting the central nervous system (CNS). Given the various causes of diplopia, it is important to differentiate between the different causes that lead to diplopia.
Differentiating Diplopia From Other Diseases
Diplopia may be caused by disorders of the orbit, extraocular muscles, neuromuscular junction dysfuntion, paralysis of the oculomotor, trochlear and abducens nerves, and injuries affecting the central nervous system (CNS). Given the various causes of diplopia, it is important to differentiate between the different causes that lead to diplopia. The following table differentiates between various causes of diplopia:
Dilopia causing disorder | Subcategory | Mechanism | Distinguising Features | Exam Findings |
Orbital disorder | Trauma |
|
|
|
Orbital apex mass[1] |
|
|
| |
Orbital cellulitis[2][3] |
|
|
| |
Thyroid-associated ophthalmopathy (Grave's disease)[4][5] |
|
|
| |
Extraocular muscle disorder | Extraocular muscle injury or hematoma[6][7] |
|
|
|
Mitochondrial myopathies[8] |
|
|
| |
Muscular dystrophy[9] |
|
|
| |
Neuromuscular junction dysfunction | Myasthenia gravis[10][11] |
|
|
|
Botulism[12] |
|
|
| |
Palsies of the third, fourth or sixth cranial nerves | Oculomotor nerve palsy |
|
|
|
Trochlear nerve palsy |
|
| ||
Abducens nerve palsy |
|
| ||
Central nervous system injury (pathways and cranial nerve nuclei) | Basilar artery thrombosis[13][14] |
|
|
|
Vertebral dissection[15][16] |
|
|
| |
Aneurysm |
|
|
| |
Wernicke's encephalopathy[17][18] |
|
|
|
References
- ↑ "thejns.org".
- ↑ Chaudhry IA, Al-Rashed W, Arat YO (January 2012). "The hot orbit: orbital cellulitis". Middle East Afr J Ophthalmol. 19 (1): 34–42. doi:10.4103/0974-9233.92114. PMID 22346113.
- ↑ Lee S, Yen MT (January 2011). "Management of preseptal and orbital cellulitis". Saudi J Ophthalmol. 25 (1): 21–9. doi:10.1016/j.sjopt.2010.10.004. PMID 23960899.
- ↑ Şahlı E, Gündüz K (April 2017). "Thyroid-associated Ophthalmopathy". Turk J Ophthalmol. 47 (2): 94–105. doi:10.4274/tjo.80688. PMID 28405484.
- ↑ Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC (2015). "Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management". J Ophthalmol. 2015: 249125. doi:10.1155/2015/249125. PMID 26351570.
- ↑ Thacker NM, Velez FG, Demer JL, Wang MB, Rosenbaum AL (2005). "Extraocular muscle damage associated with endoscopic sinus surgery: an ophthalmology perspective". Am J Rhinol. 19 (4): 400–5. PMID 16171176.
- ↑ Chen J, Kang Y, Deng D, Shen T, Yan J (September 2015). "Isolated Total Rupture of Extraocular Muscles". Medicine (Baltimore). 94 (39): e1351. doi:10.1097/MD.0000000000001351. PMID 26426604.
- ↑ Schrier SA, Falk MJ (September 2011). "Mitochondrial disorders and the eye". Curr Opin Ophthalmol. 22 (5): 325–31. doi:10.1097/ICU.0b013e328349419d. PMID 21730846.
- ↑ "Oculopharyngeal Muscular Dystrophy - NORD (National Organization for Rare Disorders)".
- ↑ "Update on the Diagnosis of Ocular Myasthenia Gravis - American Academy of Ophthalmology".
- ↑ Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA (October 2014). "Ocular myasthenia gravis: a review". Indian J Ophthalmol. 62 (10): 985–91. doi:10.4103/0301-4738.145987. PMC 4278125. PMID 25449931.
- ↑ Khakshoor H, Moghaddam AA, Vejdani AH, Armstrong BK, Moshirfar M (May 2012). "Diplopia as the primary presentation of foodborne botulism". Oman J Ophthalmol. 5 (2): 109–11. doi:10.4103/0974-620X.99375. PMC 3441016. PMID 22993467.
- ↑ Demel SL, Broderick JP (July 2015). "Basilar Occlusion Syndromes: An Update". Neurohospitalist. 5 (3): 142–50. doi:10.1177/1941874415583847. PMID 26288672.
- ↑ von Campe G, Regli F, Bogousslavsky J (December 2003). "Heralding manifestations of basilar artery occlusion with lethal or severe stroke". J. Neurol. Neurosurg. Psychiatry. 74 (12): 1621–6. PMID 14638878.
- ↑ Park KW, Park JS, Hwang SC, Im SB, Shin WH, Kim BT (September 2008). "Vertebral artery dissection: natural history, clinical features and therapeutic considerations". J Korean Neurosurg Soc. 44 (3): 109–15. doi:10.3340/jkns.2008.44.3.109. PMID 19096659.
- ↑ Gottesman RF, Sharma P, Robinson KA, Arnan M, Tsui M, Ladha K, Newman-Toker DE (September 2012). "Clinical characteristics of symptomatic vertebral artery dissection: a systematic review". Neurologist. 18 (5): 245–54. doi:10.1097/NRL.0b013e31826754e1. PMID 22931728.
- ↑ Serlin T, Moisseiev E (2017). "Fundus Findings in Wernicke Encephalopathy". Case Rep Ophthalmol. 8 (2): 406–409. doi:10.1159/000478924. PMID 28924437.
- ↑ "Nystagmus from Wernicke's Encephalopathy | NEJM".